This represents a highly promising anti-cancer strategy, which theoretically could also potentially be repurposed to target HCMV-infected cells that overexpress HLA-E, thereby redirecting immune responses toward viral clearance rather than inhibition. This evidence concerns the gene HLA-E and cancer.